Daniel R. Chard - 04 Feb 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
04 Feb 2022
Net transactions value
+$128,667
Form type
4
Filing time
21 Apr 2022, 20:59:11 UTC
Previous filing
04 Jan 2022
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $128,667 +690 +0.67% $186.40 103,839 04 Feb 2022 The Dan and Allyson Family Irrevocable Trust F1, F2
transaction MED Common Stock Gift $0 -3,375 -17% $0.000000 16,886 23 Feb 2022 Direct F3
transaction MED Common Stock Gift $0 +3,375 +3.3% $0.000000 107,214 23 Feb 2022 The Dan and Allyson Family Irrevocable Trust F2, F3
transaction MED Common Stock Gift $0 -953 -5.6% $0.000000 15,933 21 Mar 2022 Direct F3
transaction MED Common Stock Gift $0 +953 +0.89% $0.000000 108,167 21 Mar 2022 The Dan and Allyson Family Irrevocable Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is Settlor of the Trust and Investment Trustee, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F2 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
F3 The reporting person transferred these shares to The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.